Browse study websites

Discover. Prevent. Cure.

Menu Fundraise Donate

    Recommended pages

      Do you mean

        5561-5570 of 10945 results

        Refine search

        News & Events

        Pool fencing laws will save toddlers

        Telethon Institute for Child Health Research congratulates the WA State Government on its decision not to water down pool fencing legislation. ...

        News & Events

        WA families to help find triggers for childhood leukaemia

        West Australian families are being asked to play a vital role in a major new national study to unravel the causes of childhood leukaemia. ...

        News & Events

        How well are we raising our children?

        A ground breaking study of WA 5-year olds has found that more than a quarter of the children have developmental difficulties that could have life-long impacts. ...

        Donors and Fundraisers

        How you can help Our donor community Telethon Kids is a proud recipient of the ‘Tick of Charity Registration’, awarded by the Australian Charities ...

        Spectrum

        $10m+ $1m - $9,999,999 $500k - $999,999 $100k - $499,999 $25k - $99,999 $10k - $24,999 $1 - $9,999 Ultraviolet The Australian Government BHP Bill & ...

        Current donors

        We earnestly thank every donor and also acknowledge those who prefer to remain anonymous. ...

        Exclusivity and structure

        Procurement and Supply Partner Queries Corporate Philanthropy For any procurement queries, please contact the Institute's Procurement Team. Emma ...

        Case Studies

        Procurement and Supply Partner Queries Corporate Philanthropy For any procurement queries, please contact the Institute's Procurement Team. Emma ...

        Research

        A Phase III, randomized, controlled, observer-blind study to demonstrate effectiveness, immunogenicity and safety of GSK's meningococcal Group B and combined ABCWY vaccines when administered to healthy adolescents and young adults (Quintet)

        Jennifer Peter Kent Richmond J PC RN MBBS MRCP(UK) FRACP Clinical Research Manager Head, Vaccine Trials Group Jennifer.Kent@telethonkids.org.au ...

        Research

        A randomized, controlled, observer-blind, phase 1/2a study to evaluate the safety, reactogenicity, and immunogenicity of Ad26.RSV.preF in RSV-seronegative toddlers 12 to 24 months of age

        Jennifer Peter Kent Richmond J PC RN MBBS MRCP(UK) FRACP Clinical Research Manager Head, Vaccine Trials Group Jennifer.Kent@telethonkids.org.au ...

        Page 557 of 1095